<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00273442</url>
  </required_header>
  <id_info>
    <org_study_id>PRN 05-007</org_study_id>
    <nct_id>NCT00273442</nct_id>
  </id_info>
  <brief_title>Assessing Cosopt Switch Patients</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Pharmaceutical Research Network</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Pharmaceutical Research Network</source>
  <brief_summary>
    <textblock>
      To assess the safety and efficacy of a cohort of patients switched to the dorzolamide/timolol
      maleate fixed combination because they are insufficiently controlled on latanoprost
      monotherapy.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>November 2005</start_date>
  <completion_date type="Actual">April 2007</completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <enrollment>60</enrollment>
  <condition>Ocular Hypertension</condition>
  <condition>Open-Angle Glaucoma</condition>
  <condition>Exfoliation Syndrome</condition>
  <condition>Glaucoma, Pigmentary</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>timolol maleate</intervention_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>dorzolamide/timolol maleate fixed combination</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  adults with clinical diagnosis of POAG, pigment-dispersion or exfoliation glaucoma or
             ocular hypertension

          -  the IOP on latanoprost must be 31 mm Hg or less in both eyes, and 21 to 31 mm Hg
             inclusive in at least one eye at 08:00 AM

          -  visual acuity should be 20/200 or better in each eye

        Exclusion Criteria:

          -  contraindications to study drugs

          -  anticipated change in systemic hypotensive therapy during the trial

          -  use of any corticosteroids by any route in the three months immediately prior to Visit
             2
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>William C. Stewart, MD</last_name>
    <role>Study Director</role>
    <affiliation>Pharmaceutical Research Network, LLC</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Mark J. Weiss, MD</last_name>
    <role>Principal Investigator</role>
  </overall_official>
  <overall_official>
    <last_name>Douglas G. Day, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Omni Eye Services</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Sriram Sonty, MD, FACS</last_name>
    <role>Principal Investigator</role>
    <affiliation>Midwest Eye Center</affiliation>
  </overall_official>
  <overall_official>
    <last_name>J. Charles Henry, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Little Rock Eye Clinic</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Elizabeth D. Sharpe, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Glaucoma Consultants &amp; Center for Eye Research</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Little Rock Eye Clinic</name>
      <address>
        <city>Little Rock</city>
        <state>Arkansas</state>
        <zip>72205</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Omni Eye Services</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30342</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Midwest Eye Center</name>
      <address>
        <city>Bourbonnais</city>
        <state>Illinois</state>
        <zip>60914</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Mark J. Weiss, MD</name>
      <address>
        <city>Tulsa</city>
        <state>Oklahoma</state>
        <zip>74104</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Glaucoma Consultants &amp; Center for Eye Research</name>
      <address>
        <city>Mt. Pleasant</city>
        <state>South Carolina</state>
        <zip>29464</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2008</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 6, 2006</study_first_submitted>
  <study_first_submitted_qc>January 6, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 9, 2006</study_first_posted>
  <last_update_submitted>November 18, 2008</last_update_submitted>
  <last_update_submitted_qc>November 18, 2008</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 19, 2008</last_update_posted>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Glaucoma</mesh_term>
    <mesh_term>Glaucoma, Open-Angle</mesh_term>
    <mesh_term>Ocular Hypertension</mesh_term>
    <mesh_term>Exfoliation Syndrome</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Timolol</mesh_term>
    <mesh_term>Dorzolamide</mesh_term>
    <mesh_term>Maleic acid</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

